StockData
LifeMD, Inc. logo

LifeMD, Inc. (LFMDP) stock

LFMDPNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3099% above fair value
$21.65+0.13 (+0.60%)

Close on Oct 30, 2026Market cap $110.38MP/E –Yield –

LifeMD free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

LifeMD's free cash flow for the twelve months ending Jun 30, 2026 was -$11.06M, down 161.6% year over year. For fiscal 2025 it was $6.41M, down 60.1% from the year before. The highest annual figure on record is $16.05M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.41M-60.1%
FY2024Dec 31, 2024$16.05M+86.3%
FY2023Dec 31, 2023$8.62M–
FY2022Dec 31, 2022-$23.30M–
FY2021Dec 31, 2021-$33.33M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.99M-188.9%
Q1 FY2026Mar 31, 2026$339.45K-88.5%
Q4 FY2025Dec 31, 2025-$3.44M-492.5%
Q3 FY2025Sep 30, 2025-$968.14K-115.5%
Q2 FY2025Jun 30, 2025$7.86M+101.7%
Q1 FY2025Mar 31, 2025$2.95M-41.3%
Q4 FY2024Dec 31, 2024$875.39K-84.4%
Q3 FY2024Sep 30, 2024$6.25M+497.6%
Q2 FY2024Jun 30, 2024$3.90M-15.5%
Q1 FY2024Mar 31, 2024$5.03M–
Q4 FY2023Dec 31, 2023$5.60M–
Q3 FY2023Sep 30, 2023$1.05M–
Q2 FY2023Jun 30, 2023$4.61M–
Q1 FY2023Mar 31, 2023-$2.65M–
Q4 FY2022Dec 31, 2022-$1.96M–
Q3 FY2022Sep 30, 2022-$2.80M–
Q2 FY2022Jun 30, 2022-$10.19M–
Q1 FY2022Mar 31, 2022-$8.36M–
Q4 FY2021Dec 31, 2021-$6.00M–
Q3 FY2021Sep 30, 2021-$7.47M–

More LifeMD figures